Manchester Capital Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$283K Sell
1,131
-12
-1% -$2.99K 0.04% 229
2025
Q4
$314K Buy
1,143
+12
+1% +$3.28K 0.04% 221
2025
Q3
$297K Buy
1,131
+12
+1% +$2.92K 0.04% 261
2025
Q2
$245K Sell
1,119
-27
-2% -$5.77K 0.03% 312
2025
Q1
$257K Buy
1,146
+11
+1% +$3.03K 0.03% 298
2024
Q4
$372K Buy
1,135
+8
+0.7% +$2.52K 0.04% 248
2024
Q3
$338K Buy
1,127
+24
+2% +$7.35K 0.04% 267
2024
Q2
$363K Sell
1,103
-5
-0.5% -$1.77K 0.04% 233
2024
Q1
$438K Buy
1,108
+2
+0.2% +$740 0.05% 203
2023
Q4
$389K Buy
1,106
+13
+1% +$4.6K 0.05% 207
2023
Q3
$410K Buy
1,093
+7
+0.6% +$2.71K 0.06% 185
2023
Q2
$415K Buy
1,086
+1
+0.1% +$357 0.06% 188
2023
Q1
$376K Hold
1,085
0.05% 216
2022
Q4
$255K Sell
1,085
-6
-0.5% -$1.42K 0.04% 219
2022
Q3
$268K Buy
1,091
+6
+0.6% +$1.83K 0.05% 190
2022
Q2
$328K Sell
1,085
-3
-0.3% -$976 0.06% 174
2022
Q1
$447K Hold
1,088
0.06% 172
2021
Q4
$510K Sell
1,088
-1
-0.1% -$430 0.07% 161
2021
Q3
$462K Buy
1,089
+4
+0.4% +$1.69K 0.06% 175
2021
Q2
$390K Hold
1,085
0.05% 192
2021
Q1
$306K Sell
1,085
-4
-0.4% -$1.15K 0.05% 220
2020
Q4
$309K Buy
1,089
+4
+0.4% +$1.12K 0.05% 197
2020
Q3
$298K Hold
1,085
0.05% 191
2020
Q2
$246K Hold
1,085
0.03% 218
2020
Q1
$165K Hold
1,085
0.03% 245
2019
Q4
$163K Buy
+1,085
New +$158K 0.02% 263
2019
Q2
Sell
-300
Closed -$33K 652
2019
Q1
$33K Buy
+300
New +$31.2K ﹤0.01% 468
2016
Q1
Sell
-2,850
Closed -$172K 679
2015
Q4
$172K Hold
2,850
0.02% 232
2015
Q3
$154K Buy
+2,850
New +$166K 0.03% 231
2015
Q1
Sell
-17,020
Closed -$906K 913
2014
Q4
$906K Sell
17,020
-3,300
-16% -$165K 0.11% 72
2014
Q3
$910K Buy
20,320
+2,370
+13% +$101K 0.12% 69
2014
Q2
$757K Hold
17,950
0.1% 95
2014
Q1
$791K Buy
17,950
+2,190
+14% +$103K 0.13% 86
2013
Q4
$773K Hold
15,760
0.12% 90
2013
Q3
$649K Hold
15,760
0.11% 98
2013
Q2
$554K Buy
+15,760
New +$519K 0.1% 101

Other funds holding WST